ESC Premium Access

Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Congress Presentation

About the speaker

Doctor Craig Coleman

University of Connecticut , Storrs (United States of America)
10 presentations
0 follower

6 more presentations in this session

Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Speaker: Doctor W. Chang (Tainan, TW)


Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)


Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Speaker: Doctor K. Hellenkamp (Goettingen, DE)


A novel experimental in vivo model of acute pulmonary embolism

Speaker: Doctor J. Schultz (Aarhus, DK)


The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Speaker: Doctor E. Klok (Leiden, NL)


Access the full session

What is new in venous thromboembolism?

Speakers: Doctor C. Coleman, Doctor W. Chang, Ms C. Sindet-Pedersen, Doctor K. Hellenkamp, Doctor J. Schultz...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb